Drug Profile
AGN 201904Z
Alternative Names: AGN 201904; AGN 201904-Z; CMA-omeprazoleLatest Information Update: 18 May 2020
Price :
$50
*
At a glance
- Originator Allergan
- Class Antiulcers
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Gastric ulcer
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 31 Dec 2006 Phase-II clinical trials in Gastric ulcer in USA (PO)
- 31 Jul 2004 Preclinical trials in Gastrointestinal disorders in USA (unspecified route)